These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 851454)

  • 1. Evidence of tumorigenic activity of candidate cell substrates in vaccine production by use of antilymphocyte serum.
    Glathe H; Abel C
    Dev Biol Stand; 1977; 34():145-8. PubMed ID: 851454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterotransplantability testing in nude mice of candidate cell for vaccine production.
    Kairouannais M; Nicolas A
    Dev Biol Stand; 1980; 45():137-42. PubMed ID: 6967435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of cell culture tumorigenic activity by heterotransplantation into hamster cheek pouch tissue using immunodepressants].
    Avakova AN; Rozina EE; Stepanova LG; Andzhaparidze OG
    Vopr Virusol; 1976; (2):211-6. PubMed ID: 936580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of positive controls in testing the oncogenic potential of cell material for virus vaccine production.
    Rau C; Voiculescu C; Palade V
    Dev Biol Stand; 1976 Dec 13-15; 37():241-4. PubMed ID: 1031687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial transplantation of Burkitt's tumor (EB3) cells in newborn Syrian hamsters and its facilitation by antilymphocyte serum.
    Adams RA; Foley GE; Frber S; Flowers A; Lazarus H; Hellerstein EE
    Cancer Res; 1970 Feb; 30(2):338-45. PubMed ID: 4917979
    [No Abstract]   [Full Text] [Related]  

  • 6. Carcinogenesis in tissue culture 27: heterotransplantation as an alternative in vivo assay for neoplastic state of cells in culture.
    Sakakibara K; Takaoka T; Katsuta H
    Jpn J Exp Med; 1976 Aug; 46(4):457-62. PubMed ID: 1086916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Further use of antithymocyte serum].
    Huang NJ
    Zhonghua Zhong Liu Za Zhi; 1985 Jul; 7(4):244-6. PubMed ID: 4085311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumourigenicity testing in immunosuppressed mice: advantages and disadvantages.
    Stanbridge EJ; Perkins FT
    Dev Biol Stand; 1976 Dec 13-15; 37():211-7. PubMed ID: 1031686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumorigenicity testing of various cell substrates for production of biologicals.
    Furesz J; Fanok A; Contreras G; Becker B
    Dev Biol Stand; 1989; 70():233-43. PubMed ID: 2759351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Demonstration of the oncogenic activity of cell cultures using antithymocytic serum].
    Abel C; Glathe H
    J Hyg Epidemiol Microbiol Immunol; 1978; 22(3):375-81. PubMed ID: 311797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacillus Calmette-Guérin and antilymphocyte serum in carcinogenesis. Effects on the hamster pouch.
    Giunta JL; Reif AE; Shklar G
    Arch Pathol; 1974 Oct; 98(4):237-40. PubMed ID: 4606260
    [No Abstract]   [Full Text] [Related]  

  • 12. Subcutaneously inoculated cells and implanted pancreatic cancer tissue show different patterns of metastases in Syrian golden hamsters.
    Morioka CY; Saito S; Ohzawa K; Asano S; Hibino Y; Nakada Y; Kita KI; Watanabe A
    JOP; 2000 Nov; 1(4):183-90. PubMed ID: 11856860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterotransplantation of cell lines derived from human malignant neoplasms into golden hamsters treated with antithymocyte serum.
    Sakakibara K; Oota K
    Jpn J Exp Med; 1975 Dec; 45(6):501-14. PubMed ID: 1085379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposals on the control of VERO cells used to prepare inactivated poliomyelitis vaccine.
    Ménetrat JL; Chaniot S; Lefrançois S; Canale A; Chippaux A
    Dev Biol Stand; 1981; 47():163-7. PubMed ID: 6785125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assay for cell tumorigenicity in subhuman primates treated with antilymphocyte globulin.
    Petricciani JC; Kirschstein RL; Wallace RE; Martin DP
    J Natl Cancer Inst; 1972 Mar; 48(3):705-13. PubMed ID: 4621740
    [No Abstract]   [Full Text] [Related]  

  • 16. Loss of controlled nuclear division in BHK21 cells passed in vivo.
    O'Neill FJ
    Cancer Res; 1976 Jun; 36(6):2019-24. PubMed ID: 944618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinogenesis in tissue culture 25: reduced tumorigenicity of alkaline phosphatase-constitutive variants from Chinese hamster ovary cells.
    Nose K; Sakakibara K
    Jpn J Exp Med; 1975 Oct; 45(5):327-34. PubMed ID: 1083437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumorigenicity of a rabbit lymphoid cell line transformed by human T-cell leukemia virus.
    Miyoshi I; Kubonishi I; Yoshimoto S; Ohtsuki Y; Akagi T
    Gan; 1984 Jun; 75(6):482-4. PubMed ID: 6088346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety characterization of HeLa-based cell substrates used in the manufacture of a recombinant adeno-associated virus-HIV vaccine.
    Tatalick LM; Gerard CJ; Takeya R; Price DN; Thorne BA; Wyatt LM; Anklesaria P
    Vaccine; 2005 Apr; 23(20):2628-38. PubMed ID: 15780446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies of the origin of malignant rhabdoid tumor(MRT)--experimental researches on the MRT evolving in nude mice inoculated with violently variable HeLa cells].
    Zhang DL; Huang GS; Li LJ; He XY; Xia GT; Gao BX; Bai XH; Liu SG
    Yi Chuan Xue Bao; 2000; 27(12):1057-71. PubMed ID: 11209698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.